What will Dupixent (dupilumab) cost in 2026?
The exact “cost price” of Dupixent in 2026 depends on the country, the dispensing channel (hospital vs. retail pharmacy), whether you’re paying cash or billed through insurance, and the specific pack size/strength. The information provided here doesn’t include any 2026 pricing schedule or official 2026 list price for Dupixent, so a precise 2026 figure can’t be stated from this material.
Is there an official 2026 list price for Dupixent?
If you mean the manufacturer’s list price, those figures are usually set by each country’s pricing authority (or via national tender/pricing rules), and they can change year to year. Without the relevant jurisdiction and an official price source, the 2026 list price isn’t determinable.
How do people usually find the 2026 “cost price” for Dupixent?
Users typically check:
- The country’s medicine price database or reimbursement directory (national list price and/or reimbursed price)
- Hospital procurement or tender prices (often lower than retail list prices)
- Pharmacy cash prices (often higher and variable by retailer)
- Insurance/EOB (your out-of-pocket can differ greatly from the “cost price”)
Which country are you asking about?
Reply with the country (and if possible the pack size/strength, e.g., 200 mg/300 mg or pen/syringe), and whether you mean:
- list price (before insurance),
- reimbursed price (after government/insurer),
- or out-of-pocket cost for a typical patient.
Then I can narrow the answer to what’s relevant for 2026 in that location.
What could change Dupixent pricing by 2026?
Even without a specific 2026 number, pricing can shift due to:
- new reimbursement rules or tender outcomes,
- discounts or rebates negotiated by payers,
- changes in dosing frequency for particular indications,
- and market competition from other biologics or biosimilars (if/where they’re available).
Quick clarification
What country are you in, and do you want list price, reimbursed price, or your out-of-pocket cost in 2026?